Delivery of stem cell therapy for Parkinson’s safe in primate trial
A transplant approach used to deliver ANPD001, an investigational stem cell therapy for Parkinson’s disease, to the brain was…
Articles by Lindsey Shapiro, PhD
Many Parkinson’s clinical trials fail to reach Phase 3, report says
The number of active Parkinson’s disease clinical trials has remained relatively stable since 2019, but many investigational therapies…
Parkinson’s risk doubles in older adults with anxiety: UK study
The risk of developing Parkinson’s disease is double in adults older than 50 with anxiety relative to those without…
Therapeutic Parkinson’s vaccine safely inhibits alpha-synuclein
UB-312, a therapeutic vaccine candidate from Vaxxinity, safely led to antibodies being produced that could target toxic clumps of…
FDA issues second rejection of ABBV-951 for motor fluctuations
The U.S. Food and Drug Administration (FDA) has rejected for the second time AbbVie’s application of ABBV-951 (foscarbidopa/foslevodopa)…
Gut microbes play role in age-related inflammation: Mouse study
Gut microbes may play an important role in driving the low-grade inflammation that naturally occurs with aging and is exacerbated…
Blocking metabolizing bacteria may boost levodopa in Parkinson’s
Preventing the growth of gut bacteria that cause levodopa (L-dopa) to be broken down before it reaches the brain could…
Spinal cord stimulation may aid Parkinson’s posture problems: Study
Spinal cord stimulation (SCS) was able to safely improve postural problems for people with Parkinson’s disease, according to a…
MJFF funds biomarker research to improve Parkinson’s clinical trials
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded $9.75 million to researchers working on validating new…
AI algorithm uses smartwatch data to predict Parkinson’s emotions
Researchers have developed an algorithm that uses artificial intelligence (AI) to recognize the emotional states of people with Parkinson’s…